Greetings!


SoCalBio Mast
SoCalBio Weekly Update

Past Weekly Updates

SoCalBio Vendor Spotlight

 

JP Tech Insurance Services, Inc. 

A SoCalBio Member Since 2002

 

Led by Mr. Joseph Plascentia (photo above), JP Tech Insurance Services, Inc. provides insurance and risk management services to the biotechnology and medical device industries ... Learn more

 

 

SoCalBio Partners

 

 

vince

 

 

vince

  NP

 

vince

Replenish, Inc.

airgas  

 

Los Angeles/Orange County Biotechnology Center 

vince

 

onelambda 

 SoCalBio Mast  

 

 

stradlinglogo

trinet

onelambda

officedepot
 

 

Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
Become a Member
Thanks to SoCalBio Media Partners


February 19,  2013



Editor: Ahmed Enany 
President & CEO
Southern California
Biomedical Council

enany@socalbio.org

www.socalbio.org

Featured Story

The Los Angeles-Based Second Sight Wins FDA Approval of its Breakthrough Implantable Bionic Eye

 

Second Sight Medical Products has won FDA approval for its Argus II bionic eye for the treatment of late stage Retinitis Pigmentosa (RP). This announcement comes after the European approval in 2011, and widespread support from the FDA's Ophthalmic Devices Advisory panel. The Argus II system was apparently shortlisted for approval under the Humanitarian Device Exemption, which has been put in place to expedite technologies for under-served patient populations.
 
rob Greenberg "We are thrilled to be able to offer the only FDA-approved long-term therapy for people suffering from advanced RP," said Robert Greenberg, MD, PhD (photo right), President and CEO of Second Sight. "With this approval, we look forward to building a strong surgical network in the United States and recruiting new hospitals that will offer the Argus II retinal implant. This is a game changer in sight-affecting diseases, that represents a huge step forward for the field and for these patients who were without any available treatment options until now" ... Read company Press Release 
 
Watch YouTube Video about Second Sight's Breakthrough Device
Second Sight EN 2012 Argus II Retinal Prosthesis System Artificial Retina Bionic Eye
 
Crowdfunding

Crowdfunding for the Biosciences:

A Real Prospect or Pipe Dream
 
CNSI Auditorium at UCLA
570 Westwood Plaza, Los Angeles, CA 90095
Thursday, February 28, 2013 from 4:00 PM to 7:00 PM

 

Eventbrite - SoCalBio Networking Forum: Crowdfunding for the Biosciences: A Real Prospect or Pipe Dream
 
Crowdfunding promises to give some startups access to capital they wouldn't have had otherwise, but it could also set up unprepared entrepreneurs for a headache. This SoCalBio mixer will provide a primer on this source of funding and discuss all the legal, accounting, and business strategy aspects of crowdsourcing for bioscience commercialization projects. 

Our Speakers and panelists will touch on:
  • How to crowdfund by reaching out to people in your network
  • How to tap into their desire to support your project and believe in your claims
  • How to keep crowdfunding legal
  • Are there crowdfunding best practices?
  • Is it realistic to crowdsource for biotech or medical device projects?
  • Will crowdsourcing hurt your chances of tapping into institutional money

Speakers

  • Howard Leonhardt, Founder & Chairman, California Stock Exchange
  • Carl Esposti, Founder Crowdsourcing.org & CEO, Massolution
  • David Harvilicz, Founder & CEO, WhenYouWish.com

Panel Discussion

  • Joseph A. Boystak, President & CEO, Brightwaters Capital
  • George Colindres, Sr Counsel, Perkins Coie
  • Eric Miles, Partner, Moss Adams
  • Roger Zickfeld, Managing Director, Zickfeld Capital Advisors
Public Policy

Healthcare reform: What Should the Medical Device Industry Expect from the Sunshine Act?

 

A Mass Device interview with Jonathan Kellerman, compliance and risk management expert at PricewaterhouseCoopers about the Sunshine Act. Kellerman contends that medical device companies should brace for some unintended consequences after the Centers for Medicare & Medicaid Services announcement of the rules in relationship to the Physician Payment Sunshine Act ....  Read more 

Emerging Markets

The Far East Is Becoming the Wild West for Med-tech

 

Medtronic's acquisition of Changzhou Holdings and Stryker's decision to buy Trauson Holdings signal an emerging trend of companies eager to dip into new markets in 2013, especially China ... Read more

Join SoCalBio

Become a SoCalBio Member and Save Money by Utlizing the SoCalBio Group Purchasing Program

New Incubator

Former Amgen Scientist Starts an Incubator in Thousand Oaks

 

The San Fernando Valley Business Journal featured the new incubator started in Thousand Oaks by Greg Cauchon (photo right). The incubator is called the New Ventura BioCenter. This incubator provides wet-lab and office space for short- or medium-term lease. The BioCenter helps startup firms accelerate their discovery and development efforts through to a successful exit ... Access article (requires subscription)

New Funding

The Goleta-Based Obesity Device Company BaroNova Raises $27 Million

 

This C round for weight loss device maker BaroNova is led by Boston Scientific, Sante Ventures, Lumira Capital and a bevy of other venture capital shops. BaroNova is developing a "transpyloric shuttle," inserted endoscopically into the stomach to slow digestion and create a feeling of satiety which should slow or stop patients from overeating ... Read more

 

Other Recent Greater Los Angeles Venture Funding Deals

  • The Marina del Rey-Based Tribogenics Raises $6.2 Million Series A Round Led by Founders Fund ... Read more
  • The Laguna Hills-based Glaukos Corp., a developer of a glaucoma device, has raised $30 million in new VC funding ... Read more
  • The Irvine-based Ivantis, a developer of glaucoma stent, has raised $27 million in a first closing of its Series B funding ...Read more
Supported Event
chris
Biomed Innovation Summit 2013
14-15th March, 2013  SHANGHAI, CHINA
Patenting
Stellar Biotechnologies Files Provisional Application for Patent for KLH Adjuvant Innovations 
 
The new innovations are related to Stellar's Keyhole Limpet Hemocyanin ("KLH")-based combinatorial adjuvant technology. The application included claims for pharmaceutical grade adjuvant compositions, manufacturing processes and uses in a wide range of vaccine therapies ... Read more
Biotech Real Estate Opportunity
agensys-building     agensys-building2
Rare Biotech Sublease Opportunity in Santa Monica
Approx 28,000 Total Contiguous Rentable Square Feet 
Contact Matthew Brainard

Sr.Managing Director, Studley

310.444.1026 --  mbrainard@studley.com

License: 01267600 

  • Asking rate: $2.50 NNN with 3% annual increases 
  • 1545 17th St. approximately 18,000 rsf. through September 30, 2016 
  • 1701 Colorado Ave. / 1553 17th St. approximately 10,000 rsf through October 31, 2016 
  • Longer terms may be available 
  • Available December 1, 2013 
  • Creative office potential 
  • Two buildings combined currently improved as a biotechnology manufacturing facility, including: generator, clean rooms, laboratory space, hoods, autoclaves, etc 
  • Approx. 62 car parking (including lot across the street at 1544 17th St.) 
  • Located in the heart of the Santa Monica Media District and across the street from a future Metro stop
New SoCalBio Members

Globizz (Gardena)

 

Globizz is an international consulting company with extensive experience in cross-border business. The company provides strategic planning and risk management services to Japanese companies interested in expansion in the US  and American companies interested in doing business in Japan... Learn more

  

Interlean LLC (Lawndale)

 

Interlean is created by Mr William Botha, formerly with Baxter Biosciences and Avrio Biopharmaceuticals, to offer Lean deployment services customized to fit the needs of the tightly regulated pharmaceutical and medical device companies ...learn more

 

Quantason (Los Angeles)

 

Quantason has developed a revolutionary, next-generation bi-modal (US/IDUS) platform technology which fundamentally changes the utilization of conventional ultrasound both as a modality for diagnostic imaging and as an active screening method ... Learn more

 

Amethyst Life Sciences 

@ the New Ventura BioCenter (Thousand Oaks)

 

Amethyst Life Sciences, Inc., is a privately-funded company whose mission is to enable new start-up businesses in the areas of biotechnology, pharmaceutical science, nanotechnology, and materials science ... Learn more

 

Exact Staff, Inc. (Woodland Hills)

 

exactstaff Exact Staff is a healthcare and medical device staffing service provider. The company will be represented in SoCalBio by its CEO Ms. Karen Goodwin kgoodwin@exactstaff.com  ... Learn more

Jobs Available
                              Avita Medical (Northridge)
                                Bioject (Orange County)
                                       Ivantis (Irvine)
About SoCalBio 
 
SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio